Journal of Ovarian Research

Article	Citations
The efficacy and safety of angiogenesis inhibitors for recurrent ovarian cancer: a meta‑analysis	177
The prolactin receptor gene (PRLR) is linked and associated with the risk of polycystic ovarian syndrome	160
Ovarian tissue cryopreservation in a patient with breast cancer during pregnancy: a case report	78
Correction: Metformin modifies plasma microbial-derived extracellular vesicles in polycystic ovary syndrome with insulin resistance	73
Fertility-sparing surgery in children and adolescents with borderline ovarian tumors: a retrospective study	61
HOXB2 promotes cisplatin resistance by upregulating lncRNA DANCR in ovarian cancer	61
Integrated multi-omics analysis identifies TLR4-mediated mechanisms in ATBC-induced ovarian dysfunction and female infertility: A network toxicology, transcriptomic, and Mendelian randomization study	58
Prognostic significance and risk factors for pelvic and para-aortic lymph node metastasis in type I and type II ovarian cancer: a large population-based database analysis	57
Effects of vitrified cryopreservation duration on IVF and neonatal outcomes	52
Long noncoding RNA SNHG25 promotes the malignancy of endometrial cancer by sponging microRNA-497-5p and increasing FASN expression	51
BRCA1 and BRCA2 deficient tumour models generate distinct ovarian tumour microenvironments and differential responses to therapy	47
Evaluation of calcification distribution by CT-based textural analysis for discrimination of immature teratoma	47
Generation of healthy bovine ovarian organoids: a proof-of-concept derivation technique	47
Comparison of oocyte vitrification using a semi-automated or a manual closed system in human siblings: survival and transcriptomic analyses	46
Ginseng alleviates folliculogenesis disorders via induction of cell proliferation and downregulation of apoptotic markers in nicotine-treated mice	45
The presence of ovarian endometrioma adversely affect ovarian reserve and response to stimulation but not oocyte quality or IVF/ICSI outcomes: a retrospective cohort study	44
Expression of long noncoding RNAs in the ovarian granulosa cells of women with diminished ovarian reserve using high-throughput sequencing	41
Causal relationship between inflammatory cytokines and polycystic ovary syndrome: a bidirectional mendelian randomization study	41
Targeted proteomics of plasma extracellular vesicles uncovers MUC1 as combinatorial biomarker for the early detection of high-grade serous ovarian cancer	40
Protective effect of Luffa cylindrica fermentation liquid on cyclophosphamide-induced premature ovarian failure in female mice by attenuating oxidative stress, inflammation and apoptosis	35
Pre-operative plasma VEGF-C levels portend recurrence in epithelial ovarian cancer patients and is a bankable prognostic marker even in the initial assessment of a patient	34
Differences of survival benefits brought by various treatments in ovarian cancer patients with different tumor stages	34
Retrospective analysis of GnRH-a prolonged protocol for in vitro fertilization in 18,272 cycles in China	32
Impact of obesity on proteomic profiles of follicular fluid-derived small extracellular vesicles: A comparison between PCOS and non-PCOS women	30
Comprehensive in silico analysis of prognostic and immune infiltrates for FGFs in human ovarian cancer	30

The PAPSS1 gene is a modulator of response to cisplatin by regulating estrogen receptor alpha signaling activity in ovarian cancer cells	29
Prognostic marker C3AR1 is associated with ovarian cancer cell proliferation and immunosuppression in the tumor microenvironment	29
Cocultured porcine granulosa cells respond to excess non-esterified fatty acids during in vitro maturation	27
LncRNA DANCR counteracts premature ovarian insufficiency by regulating the senescence process of granulosa cells through stabilizing the interaction between p53 and hNRNPC	27
Analysis of prognostic value of lactate metabolism-related genes in ovarian cancer based on bioinformatics	26
Personalization of IVF-ICSI workflow based on patient characteristics improves IVF laboratory outcomes and embryo ploidy by PGT-A	26
Causal association between metabolic syndrome and ovarian dysfunction: a bidirectional two-sample mendelian randomization	25
Comparison of the quality of ovarian tissue cryopreservation by conventional slow cryopreservation and vitrification—a systematic review and meta-analysis	25
High expression of RIPK2 is associated with Taxol resistance in serous ovarian cancer	25
The stromal microenvironment and ovarian aging: mechanisms and therapeutic opportunities	24
Comparative efficacy and safety of metformin, anti-obesity agents, and myoinositol in improving IVF/ICSI outcomes and reducing ovarian hyperstimulation syndrome in women with polycystic ovary syndrome	24
An integrated machine learning-based model for joint diagnosis of ovarian cancer with multiple test indicators	24
Premature ovarian insufficiency: a review on the role of tobacco smoke, its clinical harm, and treatment	24
In vitro drug testing using patient-derived ovarian cancer organoids	24
Plasma circRNA microarray profiling identifies novel circRNA biomarkers for the diagnosis of ovarian cancer	24
Laser-assisted hatching is associated with reduced re-expansion of vitrified-thawed blastocysts and has no significant effect on embryo implantation	24
Near-infrared fluorescent molecular probes with cetuximab in the in vivo fluorescence imaging for epithelial ovarian cancer	24
Folliculogenesis and steroidogenesis alterations after chronic exposure to a human-relevant mixture of environmental toxicants spare the ovarian reserve in the rabbit model	23
MiR-149-3p promotes the cisplatin resistance and EMT in ovarian cancer through downregulating TIMP2 and CDKN1A	23
Stem cell treatments for female reproductive disorders: a comprehensive review	23
Dose inhibin B or anti-Müllerian hormone relate to precocious puberty in girls? result of a systematic review and meta-analysis	23
Circ_0078607 inhibits the progression of ovarian cancer via regulating the miR-32-5p/SIK1 network	22
Dehydroepiandrosterone-induced polycystic ovary syndrome mouse model requires continous treatments to maintain reproductive phenotypes	22
The long non-coding RNA NEAT1 promotes the progression of human ovarian cancer through targeting miR-214-3p and regulating angiogenesis	21
Detection of plasma exosomal miRNA-205 as a biomarker for early diagnosis and an adjuvant indicator of ovarian cancer staging	21
MicroRNAs as the critical regulators of Cisplatin resistance in ovarian cancer cells	21
Synaptotagmin-like protein 1 is a potential diagnostic and prognostic biomarker in endometrial cancer based on bioinformatics and experiments	21
The pregnancy and oncology outcome of fertility-sparing management for synchronous primary neoplasm of endometrium and ovary	20
The utility of all-freeze IVF cycles depends on the composition of study populations	20
Correction: Effects and mechanisms of mUCMSCs on ovarian structure and function in naturally ageing C57 mice	20
Roles of follicle stimulating hormone and sphingosine 1-phosphate co-administered in the process in mouse ovarian vitrification and transplantation	20
Construction and evaluation of machine learning-based prediction model for live birth following fresh embryo transfer in IVF/ICSI patients with polycystic ovary syndrome	19
Sempervirine inhibits proliferation, invasion and metastasis of ovarian cancer cells and induces ultrastructural changes in vivo	19
Hyptolide induces ER stress-mediated cell death and enhances GSK3β-regulated cisplatin chemosensitivity in ovarian cancer	19
Orexin antagonism and substance-P: Effects and interactions on polycystic ovary syndrome in the wistar rats	19
The application value of two-dimensional ultrasound combined with contrast-enhanced ultrasound in the differential diagnosis of benign, borderline, and malignant ovarian epithelial tumors	19
Effects of different treatment methods on clinical efficacy and fertility outcomes of patients with adenomyosis	19
High expression levels of centromere protein O participates in cell proliferation of human ovarian cancer	19
The landscape of transcriptional profiles in human oocytes with different chromatin configurations	19
Identification and validation of senescence-related genes in polycystic ovary syndrome	18
Agaricus Subrufescens ameliorates ovarian dysfunction and regulates altered biochemical parameters in rats with Letrozole induced polycystic ovarian syndrome	18
Successful treatment of Heyan Kuntai capsule combined with hormonal therapy in an adolescent with diminished ovarian reserve: a case report	18
Correction: Transcriptomics of cumulus cells – a window into oocyte maturation in humans	18
Case report: Birth achieved after effective ovarian stimulation combined with dexamethasone in a patient with resistant ovary syndrome	18
Correction: A methylation‑ and immune‑related lncRNA signature to predict ovarian cancer outcome and uncover mechanisms of chemoresistance	18
Polycystic ovary rat model exposure to 150 kHz intermediate frequency: hypothalamic-pituitary-ovarian axis at the receptor, cellular, tissue, and hormone levels	18
CRISPR/Cas9-mediated activation of NR5A1 steers female human embryonic stem cell-derived bipotential gonadal-like cells towards a steroidogenic cell fate	18
Downregulation of FASN in granulosa cells and its impact on ovulatory dysfunction in PCOS	17
Role of different non-coding RNAs as ovarian cancer biomarkers	17
Development and validation of an ultrasound‑based radiomics nomogram to predict lymph node status in patients with high-grade serous ovarian cancer: a retrospective analysis	17

Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq	17
The live birth rate of vitrified oocyte accumulation for managing diminished ovarian reserve: a retrospective cohort study	17
Retraction Note: Extremely active Nano-formulation of Resveratrol (XAR™) attenuates and reverses chemotherapy-induced damage in mice ovaries and testes	17
Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis	17
Mesonephric-like adenocarcinoma of the ovary	17
Ultrasonographic and histopathological investigation of the effect of N-acetylcysteine on doxorubicin-induced ovarian and uterine toxicity in rats	16
Clinical significance and biological roles of lncRNA CTBP1-AS in polycystic ovary syndrome	16
High visceral fat-to-muscle ratio is an independent factor that predicts worse overall survival in patients with primary epithelial ovarian, fallopian tube, and peritoneal cancer	16
Rare variants in GPR3 in POI patients: a case series with review of literature	16
Unveiling the link: anti-protein disulfide isomerase A3 autoantibody expression and polycystic ovary syndrome risk in euthyroid autoimmune thyroiditis women	16
Effects of coenzyme q10 supplementation on metabolic and reproductive outcomes in obese rats	16
Correction to: Knockdown of heat shock protein family D member 1 (HSPD1) promotes proliferation and migration of ovarian cancer cells via disrupting the stability of mitochondrial 3-oxoacyl-ACP syntha	16
Extracellular vesicle-microRNAs mediated response of bovine ovaries to seasonal environmental changes	16
Exosomal circ_0008285 in follicle fluid regulates the lipid metabolism through the miR-4644/ LDLR axis in polycystic ovary syndrome	15
Anti-Müllerian hormone independently affect mtDNA copy number in human granulosa cells	15
Development of machine learning models for diagnostic biomarker identification and immune cell infiltration analysis in PCOS	15
A primary insight into gut microbiome, MicroRNA and stemness, in a PCOS rat model	15
N-acetylcysteine supplementation improves endocrine-metabolism profiles and ovulation induction efficacy in polycystic ovary syndrome	14
Quercetin alleviates cyclophosphamide-induced premature ovarian insufficiency in mice by reducing mitochondrial oxidative stress and pyroptosis in granulosa cells	14
Exploring causal relationships between brain imaging-derived phenotypes and ovarian cancer risk: a bidirectional Mendelian randomization	14
NB compounds are potent and efficacious FOXM1 inhibitors in high-grade serous ovarian cancer cells	14
LncRNA-MSC-AS1 inhibits the ovarian cancer progression by targeting miR-425-5p	14
miR-34a-5p modulation of polycystic ovary syndrome via targeting the NOTCH signaling pathway	14
Identification of TRPM2 as a prognostic factor correlated with immune infiltration in ovarian cancer	14
Acetylation model predicts prognosis of patients and affects immune microenvironment infiltration in epithelial ovarian carcinoma	14
A methylation- and immune-related lncRNA signature to predict ovarian cancer outcome and uncover mechanisms of chemoresistance	14
Mechanistic and therapeutic insight into the effects of cinnamon in polycystic ovary syndrome: a systematic review	14
RNA-binding protein IGF2BP2 enhances circ_0000745 abundancy and promotes aggressiveness and stemness of ovarian cancer cells via the microRNA-3187-3p/ERBB4/PI3K/AKT axis	14
Clinical significance for combined coagulation indexes in epithelial ovarian cancer prognosis	14
Exosomal biomarkers in the differential diagnosis of ovarian tumors: the emerging roles of CA125, HE4, and C5a	13
Tanshinone IIA alleviates tri-ortho-cresyl phosphate-induced ovarian damage through Hippo signaling pathway activation in mice	13
The cumulative live birth rate of recombinant follicle-stimulating hormone alfa verse urinary human follicle-stimulating hormone for ovarian stimulation in assisted reproductive technology cycles	13
The role of MMP-14 in ovarian cancer: a systematic review	13
Treatment for ovarian clear cell carcinoma with combined inhibition of WEE1 and ATR	13
Silencing of STX4 inhibits the proliferation, migration and invasion of ovarian cancer cells via EMT/MMP2/ CCND1 signaling pathway	13
Single-cell RNA sequencing reveals the intra-tumoral heterogeneity and immune microenvironment of small cell carcinoma of the ovary, hypercalcemic type	13
Stage Ia squamous cell carcinoma as the malignant transformation of giant and unusual mature teratoma of the ovary in an elderly patient	13
The impact of clinical and laboratory parameters on clinical pregnancy and live birth rates in fresh cycles: a retrospective study of 9608 high-quality cleavage-stage embryos	13
Yijing Decoction improves premature ovarian failure in rats by activating VEGF/VEGFR-2/FAK pathway	13
Correction: Pivotal role of High-Mobility Group Box 2 in ovarian folliculogenesis and fertility	13
Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy	13
Androgen increases klotho expression via the androgen receptor-mediated pathway to induce GCs apoptosis	13
Identification of three subtypes of ovarian cancer and construction of prognostic models based on immune-related genes	13
Causal pathways linking polycystic ovary syndrome to distinct breast cancer subtypes through mediator factors: a multivariable mendelian randomization analysis	13
Histidine buffered media maintains pH stabile during cooled transportation of human ovarian tissue	13
Baicalin improves the functions of granulosa cells and the ovary in aged mice through the mTOR signaling pathway	13
Retraction Note: SLFN5 promotes reversible epithelial and mesenchymal transformation in ovarian cancer	13
Galectin-1 as a predictive biomarker in ovarian cancer	13
Linkage and association of variants in the dopamine receptor 2 gene (DRD2) with polycystic ovary syndrome	13
Association of HOMA-IR with unexpected poor ovarian response in non-obese women in poseidon 1: a retrospective cohort study	13
In-vitro generation of follicle-like structures from human germ cell-like cells derived from theca stem cell combined with ovarian somatic cells	12
Initiation and elongation factor co-expression correlates with recurrence and survival in epithelial ovarian cancer	12
High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma	12
Efficacy and safety of follitropin delta for ovarian stimulation in vitro fertilization/ intracytoplasmic sperm injection cycles: a systematic review with meta-analysis	12
Extracellular vesicles-derived MicroRNA-145-5p is upregulated in the uterine fluid of women with endometriosis and impedes mouse and human blastocyst development	12
Minimal residual disease detection by multicolor flow cytometry in cryopreserved ovarian tissue from leukemia patients	12
CAPN2 correlates with insulin resistance states in PCOS as evidenced by multi-dataset analysis	12
Single-cell RNA sequencing reveals the role of GTF2F2 in ovarian cancer oncogenesis and progression	12
Past and present: a bibliometric study on polycystic ovary syndrome	12
PAX2, PAX8, and PR are correlated with ovarian seromucinous borderline tumor with endometriosis	12
O-RADS combined with contrast-enhanced ultrasound in risk stratification of adnexal masses	12
Association between the food security status and dietary patterns with polycystic ovary syndrome (PCOS) in overweight and obese Iranian women: a case-control study	12
Cai’s prescription inhibits granulosa cell apoptosis through ARHGAP4 on poor ovarian responders	12
The emerging roles of N6-methyladenosine (m6A) deregulation in polycystic ovary syndrome	12
Causal association between telomere length and female reproductive endocrine diseases: a univariable and multivariable Mendelian randomization analysis	12
Does Anti-Müllerian hormone vary during a menstrual cycle? A systematic review and meta-analysis	12
Loss of Calponin 2 causes premature ovarian insufficiency in mice	12
Upregulation of TRPS1 promotes proliferation, migration, and invasion in ovarian clear cell carcinoma and correlates with poor patient prognosis	12
Gut microbiota and ovarian diseases: a new therapeutic perspective	12
Intra-ovarian platelet-rich plasma administration plus successive accumulated embryo transfer could be a promising strategy for poor ovarian response management: a before-after study	12
Sterigmatocystin declines mouse oocyte quality by inducing ferroptosis and asymmetric division defects	12
Genome wide identification and characterization of fertility associated novel CircRNAs as ceRNA reveal their regulatory roles in sheep fecundity	12
Pretreatment with or without GnRH-agonist before frozen–thawed embryo transfer in patients with PCOS: a systematic review and meta-analysis	12
Amplifications of EVX2 and HOXD9-HOXD13 on 2q31 in mature cystic teratomas of the ovary identified by array comparative genomic hybridization may explain teratoma characteristics in chondrogenesis and	11
Identification and validation of m5c-related lncRNA risk model for ovarian cancer	11
Baicalein improves the chemoresistance of ovarian cancer through regulation of CirSLC7A6	11
Curcumin and its formulations for the treatment of polycystic ovary syndrome: current insights and future prospects	11
Long non-coding RNA OIP5-AS1 suppresses microRNA-92a to augment proliferation and metastasis of ovarian cancer cells through upregulating ITGA6	11
Differences between complex epithelial neoplasms of the ovary and high-grade serous ovarian cancer: a retrospective observational cohort study	11
The intratumoral microbiota biomarkers for predicting survival and efficacy of immunotherapy in patients with ovarian serous cystadenocarcinoma	11

CXCL2-mediated ATR/CHK1 signaling pathway and platinum resistance in epithelial ovarian cancer	11
A real-world study of treatment patterns following disease progression in epithelial ovarian cancer patients undergoing poly-ADP-ribose polymerase inhibitor maintenance therapy	11
Epitranscriptome marks detection and localization of RNA modifying proteins in mammalian ovarian follicles	11
Clinical characteristics and risk factors of ovarian reserve decreases in women with Crohn’s disease: a case-control study	11
Multi-omics reveal the metabolic patterns in mouse cumulus cells during oocyte maturation	11
ATF3 mediates PM2.5-induced apoptosis and inflammation in ovarian granulosa cells	11
Can expelled cells/debris from a developing embryo be used for PGT?	11
Effect of Nigella sativa-L supplementation on glycemia in adolescent polycystic ovarian syndrome: secondary analysis of a randomized controlled trial study	11
Uterine involvement in epithelial ovarian cancer and its risk factors	11
LH level on ovulation trigger day has a different impact on the outcomes of agonist and antagonist regimens during in vitro fertilization	11
Effects of n-3 PUFA supplementation on oocyte in vitro maturation in mice with polycystic ovary syndrome	11
Correlation between the follicular fluid extracellular-vesicle-derived microRNAs and signaling disturbance in the oocytes of women with polycystic ovary syndrome	10
Progestin and adipoQ receptor 7 (PAQR7) mediate the anti-apoptotic effect of P4 on human granulosa cells and its deficiency reduces ovarian function in female mice	10
LncRNA DLEU1 is overexpressed in premature ovarian failure and sponges miR-146b-5p to increase granulosa cell apoptosis	10
Malignant ascites in ovarian cancer is compatible with long-term (10 year) survival with associations to clinicopathological features	10
Pretreatment with a long-acting GnRH agonist for frozen-thawed embryo transfer cycles: how to improve live birth?	10
Preparation of triangular silver nanoparticles and their biological effects in the treatment of ovarian cancer	10
Successful in vitro fertilization following conservative surgery for synchronous endometrioid tumor of ovary and uterus	10
Interlukin-22 improves ovarian function in polycystic ovary syndrome independent of metabolic regulation: a mouse-based experimental study	10
The effect of paclitaxel- and fisetin-loaded PBM nanoparticles on apoptosis and reversal of drug resistance gene ABCG2 in ovarian cancer	10
Targeting mitochondrial metabolism with CPI-613 in chemoresistant ovarian tumors	10
Fertility preservation after gonadotoxic treatments for cancer and autoimmune diseases	10
Maintenance therapy for newly diagnosed epithelial ovarian cancer– a review	10
Correction: Bone marrow mesenchymal stem cells expressing Neat-1, Hotair-1, miR-21, miR-644, and miR-144 subsided cyclophosphamide-induced ovarian insufficiency by remodeling the IGF-1–kisspeptin syst	10
Potential use of DNA methylation in cervical swabs for early ovarian cancer diagnosis	10
Proto-oncogene c-Myb potentiates cisplatin resistance of ovarian cancer cells by downregulating lncRNA NKILA and modulating cancer stemness and LIN28A-let7 axis	10
Accurate prediction of benign and malignant adnexal tumors in surgical resection and conservative treatment: construction and external validation of a diagnostic model based on CEUS, HE4, and O-RADS U	10
Serum vascular endothelial growth factor associated with the progression of granulosa cell tumor: a report of two cases	10
UBE2T regulates epithelial–mesenchymal transition through the PI3K-AKT pathway and plays a carcinogenic role in ovarian cancer	10
Machine learning models in evaluating the malignancy risk of ovarian tumors: a comparative study	10
The role of vitamin D3 in follicle development	10
Development of a necroptosis-related gene signature and the immune landscape in ovarian cancer	10
Investigation of androgen receptor CAG repeats length in polycystic ovary syndrome diagnosed using the new international evidence-based guideline	10
CircCDK17 knockdown inhibits tumor progression and cell glycolysis by downregulaing YWHAZ expression through sponging miR-1294 in cervical cancer	10
Diagnostic utility of a conventional MRI-based analysis and texture analysis for discriminating between ovarian thecoma-fibroma groups and ovarian granulosa cell tumors	10
Platelet-rich plasma activation: are there differential effects in reproductive medicine?	10
Application of comprehensive unit-based safety program model to improve chemotherapy-induced nausea and vomiting in patients with ovarian cancer: a retrospective study	10
Retraction Note: High levels of fatty acid-binding protein 5 excessively enhances fatty acid synthesis and proliferation of granulosa cells in polycystic ovary syndrome	9
Stearoyl-CoA desaturase 1 inhibition induces ER stress-mediated apoptosis in ovarian cancer cells	9
4D quantitative proteomics of ovarian granulosa cells reveals the involvement of oxidative phosphorylation in non-elderly women with diminished ovarian reserve	9
Comparison of anti-Müllerian hormone and antral follicle count in the prediction of ovarian response: a systematic review and meta-analysis	9
Preovulatory progesterone levels are the top indicator for ovulation prediction based on machine learning model evaluation: a retrospective study	9
The molecular prognostic score, a classifier for risk stratification of high-grade serous ovarian cancer	9
Predicting CD27 expression and clinical prognosis in serous ovarian cancer using CT-based radiomics	9
Extracellular vesicles and their content in the context of polycystic ovarian syndrome and endometriosis: a review	9
Targeted next-generation sequencing of 21 candidate genes in hereditary ovarian cancer patients from the Republic of Bashkortostan	9
Effects of non-pharmacological interventions on biochemical hyperandrogenism in women with polycystic ovary syndrome: a systematic review and network meta-analysis	9
Establishment of a novel CNV-related prognostic signature predicting prognosis in patients with breast cancer	9
Dynamic and functional analyses of exosomal miRNAs regulating cellular microenvironment of ovarian cancer cells	9
A risk score system based on a six-microRNA signature predicts the overall survival of patients with ovarian cancer	9
Characteristics of the vaginal microbiome in women with premature ovarian insufficiency	9
Metformin modifies plasma microbial-derived extracellular vesicles in polycystic ovary syndrome with insulin resistance	9
Paternal genetic effects of cadmium exposure during pregnancy on hormone synthesis disorders in ovarian granulosa cells of offspring	9
Unraveling the molecular mechanisms of lymph node metastasis in ovarian cancer: focus on MEOX1	9
MiR-425-5p accelerated the proliferation, migration, and invasion of ovarian cancer cells via targeting AFF4	9
Development and verification of a 7-lncRNA prognostic model based on tumor immunity for patients with ovarian cancer	8
Follicular metabolic dysfunction, oocyte aneuploidy and ovarian aging: a review	8
MSCs–derived EVs protect against chemotherapy-induced ovarian toxicity: role of PI3K/AKT/mTOR axis	8
Dingkun pill alleviates metabolic abnormalities in polycystic ovary syndrome through brown adipose tissue activation	8
Efficacy of natural products on premature ovarian failure: a systematic review and meta-analysis of preclinical studies	8
hUMSC transplantation restores follicle development in ovary damaged mice via re-establish extracellular matrix (ECM) components	8
Oligogenic basis of premature ovarian insufficiency: an observational study	8
Zishen Yutai pill ameliorates ovarian reserve by mediating PI3K-Akt pathway and apoptosis level in ovary	8
Effects of gut microbiota on omega-3-mediated ovary and metabolic benefits in polycystic ovary syndrome mice	8
Effects of single and multiple transplantations of human umbilical cord mesenchymal stem cells on the recovery of ovarian function in the treatment of premature ovarian failure in mice	8
Correction: Further characterization of adult sheep ovarian stem cells and their involvement in neo-oogenesis and follicle assembly	8
ApoC3 is expressed in oocytes and increased expression is associated with PCOS progression	8
Predictive factors of endometriosis progression into ovarian cancer	8
Letrozole increases preantral follicle growth and decreases estradiol production without impairing follicle survival	8
Transcriptomic analysis of theca cells in a PCOS rat model: insights into follicular development	8
Gengnianchun formula ameliorates insulin resistance-induced diminished ovarian reserve via the estrogen signaling pathway: evidence from network pharmacology and experimental validation	8
Correction: Novel protein-based prognostic signature linked to immunotherapeutic efficiency in ovarian cancer	8
The role of polymorphism in various potential genes on polycystic ovary syndrome susceptibility and pathogenesis	8
Adipocyte-derived CXCL10 in obesity promotes the migration and invasion of ovarian cancer cells	8
RETRACTED ARTICLE: SLFN5 promotes reversible epithelial and mesenchymal transformation in ovarian cancer	8
Effects of mind-body interventions on polycystic ovary syndrome: a comprehensive meta-analysis	8
RETRACTED ARTICLE: Extremely Active Nano-formulation of Resveratrol (XAR™) attenuates and reverses chemotherapy-induced damage in mice ovaries and testes	8
Oxidative stress and inflammatory markers in ovarian follicular fluid of women with diminished ovarian reserve during in vitro fertilization	8
Modulatory effects of R10 fraction of garlic (Allium sativum L.) on hormonal levels, T cell polarization, and fertility-related genes in mice model of polycystic ovarian syndrome	8
Medium supplementation can influence the human ovarian cells in vitro	8
Immunohistochemical markers of prognosis in adult granulosa cell tumors of the ovary – a review	8
EGF-like growth factors upregulate pentraxin 3 expression in human granulosa-lutein cells	8
The association between systemic immune-inflammation index and in vitro fertilization outcomes in women with polycystic ovary syndrome: a cohort study	8